{"id":58990,"date":"2026-01-20T15:41:08","date_gmt":"2026-01-20T10:11:08","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=58990"},"modified":"2026-01-20T15:41:13","modified_gmt":"2026-01-20T10:11:13","slug":"jagsonpal-pharmaceuticals-q3-results-expectations","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-q3-results-expectations\/","title":{"rendered":"Jagsonpal Pharmaceuticals Gears Up for Q3 Reveal on 21st January; Check Key Expectations Here"},"content":{"rendered":"<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong><em>Click and Sign Up to Get Live Updates on Q3 Results&nbsp;<\/em><\/strong><\/a><\/p><p><strong>Jagsonpal Pharmaceuticals<\/strong>, one of the most significant Indian conglomerates, is set to announce its Q3 FY26 results on 21st January 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-q3-results-expectations\/#Jagsonpal_Pharmaceuticals_Q3_Results_2026_Preview\" title=\"Jagsonpal Pharmaceuticals Q3 Results 2026 Preview\">Jagsonpal Pharmaceuticals Q3 Results 2026 Preview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-q3-results-expectations\/#Jagsonpal_Pharmaceuticals_Share_Performance\" title=\"Jagsonpal Pharmaceuticals Share Performance&nbsp;\">Jagsonpal Pharmaceuticals Share Performance&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-q3-results-expectations\/#Key_Factors_to_Watch_for_Jagsonpal_Pharmaceuticals\" title=\"Key Factors to Watch for Jagsonpal Pharmaceuticals\">Key Factors to Watch for Jagsonpal Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-q3-results-expectations\/#Final_Thoughts\" title=\"Final Thoughts\">Final Thoughts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-q3-results-expectations\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Jagsonpal_Pharmaceuticals_Q3_Results_2026_Preview\"><\/span><strong>Jagsonpal Pharmaceuticals Q3 Results 2026 Preview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\"><li>Jagsonpal Pharmaceuticals&#8217;<strong> <\/strong>revenue is expected to be in the range of \u20b974.03 crore, a 0.89% YoY decrease.\u00a0<\/li>\n\n<li>Profit After Tax, or PAT, is projected to rise by 179.17% YoY.\u00a0<\/li>\n\n<li>Jagsonpal Pharmaceuticals&#8217; EBITDA is expected to rise to \u20b936.61 crore.\u00a0<\/li>\n\n<li>Net profit is \u20b974.03 crore, a down by 0.89% YoY\u00a0<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Jagsonpal_Pharmaceuticals_Share_Performance\"><\/span><strong>Jagsonpal Pharmaceuticals Share Performance&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\"><li>Over the past six months, Jagsonpal Pharmaceuticals&#8217;s share price has fallen by 30.94% to \u20b9171.99.<\/li>\n\n<li>Moreover, over the past year, the stock has decreased by 25.64%.<\/li>\n\n<li>Despite this weak short-term performance, Jagsonpal Pharmaceuticals&#8217;s stock has delivered a financially sound 474.45% return over the past 5 years.<\/li>\n\n<li>As of 20th January 2026, the stock traded at \u20b9171.99 per share.<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Factors_to_Watch_for_Jagsonpal_Pharmaceuticals\"><\/span><strong>Key Factors to Watch for Jagsonpal Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\"><li>Brand Strength &amp; Market Position: Growth and market share of key brands (such as Indocap) across therapeutic segments, including gynaecology, pain management, and dermatology, which drive revenue and pricing power.<\/li>\n\n<li>Revenue &amp; Margin Expansion: Sustained revenue growth and improvement in EBITDA\/PAT margins through disciplined execution, cost control, and product mix optimisation.<\/li>\n\n<li>Product Pipeline &amp; New Launches: Introduction of new formulations and portfolio expansion to address unmet demand and capture higher market share.<\/li>\n\n<li>Balance Sheet &amp; Cash Generation: Strong free cash flow, working capital efficiency, and strategic use of cash for organic\/inorganic growth opportunities such as acquisitions or capacity expansion.<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Final_Thoughts\"><\/span><strong>Final Thoughts<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Jagsonpal Pharmaceuticals will announce its Q3 FY26 results on 21st January 2026. Analysts expect 0.89% YoY revenue growth, a 179.17% rise in PAT, and a 162.51% rise in EBITDA. Jagsonpal Pharmaceuticals focuses on building strong branded formulations through new product launches, therapeutic diversification, and efficient cost management to drive sustainable growth.<\/p><p><em>Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.<\/em><\/p><p><strong><em>Download the <\/em><\/strong><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest iOS App<\/em><\/strong><\/a><strong><em> or <\/em><\/strong><a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest Android App<\/em><\/strong><\/a><strong><em> to get daily stock recommendations and insightful research pieces!<\/em><\/strong><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/top-10-penny-stocks-in-india\">Top 10 Penny Stocks in India | Penny Stocks to Buy in 2026<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/best-stocks-to-buy-today-6\">Best Stocks to Buy Today: Explore Best Stocks With Expected Trends<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/milky-mist-dairy-foods-ipo-details\">Milky Mist Dairy Foods IPO Details: Everything You Should Know about<\/a>&nbsp;<\/p><p><a href=\"https:\/\/univest.in\/blogs\/karbonsteel-engineering-ipo-gmp-review\">Karbonsteel Engineering IPO GMP &amp; Review: Should You Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/taurian-mps-ipo-gmp-review\">Taurian MPS IPO GMP &amp; Review: Should You Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/shringar-house-of-mangalsutra-ipo-gmp-review\">Shringar House of Mangalsutra IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/dev-accelerator-ipo-gmp-review\">Dev Accelerator IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/vigor-plast-india-ipo-listing-preview\">Vigor Plast India IPO Listing Preview: What to Expect Now?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/krupalu-metals-ipo-gmp-live-updates-2\">Krupalu Metals IPO GMP: Day 3 IPO Live Updates<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Click and Sign Up to Get Live Updates on Q3 Results&nbsp; Jagsonpal Pharmaceuticals, one of the most significant Indian conglomerates, is set to announce its Q3 FY26 results on 21st January 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT. Jagsonpal Pharmaceuticals Q3 Results 2026 Preview<\/p>\n","protected":false},"author":23,"featured_media":58991,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3800,3801],"class_list":["post-58990","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-q3-results","tag-q3-results-2026"],"metadata":{"_edit_lock":["1768903877:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["842"],"rank_math_seo_score":["67"],"rank_math_title":["Jagsonpal Pharmaceuticals Q3 Results FY26 Preview: PAT to rise 179.17%"],"rank_math_description":["Jagsonpal Pharmaceuticals Q3 results FY26 Preview: PAT is expected to rise 179.17%, while we expect a 0.85% fall in Net Sales. Get detailed insights on quarterly results.   \n"],"rank_math_focus_keyword":["Jagsonpal Pharmaceuticals Q3 results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["58991"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["5676"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/01\/20153830\/Jagsonpal-Pharmaceuticals-Q3-Results-FY26-Expectation-PAT-to-rise-179.17.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/58990","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=58990"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/58990\/revisions"}],"predecessor-version":[{"id":58992,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/58990\/revisions\/58992"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/58991"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=58990"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=58990"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=58990"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}